Engineered probiotic heads to human trials

A probiotic bioengineered by UBC Okanagan researchers to thrive in the inflamed gut is set to enter human clinical trials in Australia this summer, capping a decade-long effort to turn a beneficial bacterium into a treatment ...

Gut bacterium and its metabolite found to delay aging

A new study published in Nature Aging on Aug. 25 reports that a single gut bacterium—Bifidobacterium pseudocatenulatum (BP)—together with a small molecule it produces, 5-aminovaleric acid betaine (5-AVAB), can alleviate multiple ...

page 5 from 40